Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2007-02-27
2007-02-27
Siew, Jeffrey (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387100, C530S387200, C530S387300, C435S326000
Reexamination Certificate
active
10793949
ABSTRACT:
Novel monoclonal antibodies and binding fragments thereof specific to human breast cancer, lung cancer, colon cancer and other cancers. The monoclonal antibody does not bind to the cell surface of normal human tissues. The corresponding cancer-specific antigen with an apparent molecular weight of 150 kd and polynucleotides encoding the antigen and the CDR regions of the antibody are Also disclosed are methods for diagnosis, prognosis and treatment of human breast cancer. The antibodies have tumor specificity and are useful for therapy, diagnosis, monitoring, detecting and imaging of cancers. The antibody-recognized cancer-specific surface antigens can serve as targets for detecting, diagnosing, inhibiting or killing cancer cells.
REFERENCES:
patent: 5811098 (1998-09-01), Plowman et al.
Corvera Joe
Hu Yudong
Serrero Ginette
Sun Le
A & G Pharmaceutical, Inc.
Li Kening
Siew Jeffrey
Yao Lei
LandOfFree
Monoclonal antibody 7H11 reactive with human cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibody 7H11 reactive with human cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibody 7H11 reactive with human cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3888464